Putting patients first at the state level — A conversation with Mark Reisenauer, President of Astellas Pharma US

Our industry continues working to improve patient access and affordability for medicines at the state level. I recently had the opportunity to connect with PhRMA board member Mark Reisenauer, President of Astellas Pharma US.

Source: The Catalyst - July 14, 2022 Category: Pharmaceuticals Authors: Scott LaGanga Tags: Economic Impact Out-of-Pocket Costs Policy Solutions Source Type: news